摘要
目的探究丁咯地尔治疗糖尿病合并急性脑血栓形成的临床价值。方法选取糖尿病合并急性脑血栓形成患者40例(2013年6月—2015年6月)作为该次研究对象,按照患者治疗方法的不同将患者分为2组,对照组患者接受复方丹参治疗,实验组则接受丁咯地尔治疗,对比2组糖尿病合并急性脑血栓形成患者治疗效果的差异性。结果实验组糖尿病合并急性脑血栓形成患者治疗效果(95.00%)优于对照组(70.00%),(P<0.05)。结论丁咯地尔治疗糖尿病合并急性脑血栓形成,可以有效改善患者功能缺损评分,减少患者脑血栓的致残率,对糖尿病合并急性脑血栓形成患者预后的改善十分有益。
Objective To explore the buflomedil clinical value for the treatment of diabetes combined with acute cerebral thrombosis. Methods Select 40 patients with diabetes mellitus complicating acute cerebral thrombosis (June 2013 - June 2015) as the research object, according to the treatment of patients with different divided the patients into two groups, con-trol group patients treated with compound salvia miltiorrhiza, the experimental group received butyl luo to treatment, com-pared two groups of diabetic patients with acute cerebral thrombosis treatment effect. Results In experimental diabetic pa-tients with acute cerebral thrombosis treatment effect (95.00%) than the control group (70.00%),(P〈 0.05). Conclusion Bu-flomedil treatment diabetes complicating acute cerebral thrombosis, can effectively improve the function defect scale, reduce the disability, in patients with cerebral thrombosis, to improve the prognosis of diabetic patients with acute cerebral throm-bosis is very good.
出处
《糖尿病新世界》
2016年第8期9-10,共2页
Diabetes New World Magazine
关键词
丁咯地尔
糖尿病
急性脑血栓
Buflomedil
Diabetes
Acute cerebral thrombus